Investment to helpLablink grow into leading diagnostics provider across Southeast Asia.

Singapore / New Delhi, 23January 2018– Quadria Capital, Asia’s leading private healthcare investor, today announceditsinvestment partnership withMalaysia’s leading diagnostics provider, Lablink (M) Sdn Bhd, as part of a wider strategy to expand into the medical laboratory servicessector.


The partnership will also allow QuadriaCapital to support Lablink’s growth in the Malaysian market and its diversification across Southeast Asia.


This isQuadria Capital Fund L.P.’s eighth investment across Southeast and South Asia since its launch in 2015.


Lablink is a subsidiary of Malaysia’s leading private healthcare provider KPJ Healthcare Berhad. The companywas initially established in 1989 and subsequently acquired by the KPJ group in 1991 to manage all the hospital laboratories within the KPJ Group. Headquartered in Kuala Lumpur, Lablink currently provides diagnostic services to the KPJ Group of hospitals and other healthcare providers in Malaysia.


With over 400 service staff, Lablink offers high quality diagnostic services through operating its central laboratory, as well as managing the hospital laboratories for KPJ Group hospitals. Its comprehensive service offerings include haematology, chemical pathology, immunology & serology, histology, biosafety & mycobacteriology, medical microbiology, cytology, molecular diagnostics, and health screening packages.


Quadria Capital Managing Partner and Co-Founder Abrar Mir said:“We believe that the region’sdiagnostics industryis ripe for consolidation andLablink is wellpositioned to become a leading pan-Southeast Asian diagnostics provider. Its ambition dovetails with Quadria Capital’s investment philosophy of supporting healthcare businesses that are focused on delivering quality care across the region.


“Our partnership withLablink will allow the company to leverage Quadria Capital’s experience in growing diagnostics providers across the region, as well as other synergistic opportunities arising fromour portfolio and network.”


KPJ Healthcare President and Managing Director Dato’ Amiruddin Abdul Satarsaid:“We believe that the partnership with QuadriaCapital will help launch Lablink into its next phase of growth, given Quadria’s deep operating knowledge and experience of building healthcare businesses around the region,and we look forward to working closely with theteam.”


Lablink Executive Director Ahmad Nasirruddin Harun added: “We have already developed a detailed business plan and we are ready to focus on implementing a number of near-term initiatives now that the partnership terms have been finalised.”


Demand for diagnostics has been rising rapidly across Southeast Asia with growing awareness and increase in disposable income.A partnership with QuadriaCapital will also strengthen Lablinkto capture demand beyond the KPJ Group hospitals. Another key focus of the partnership is to implement Lablink’s strategic expansionplan across the region to become the leading diagnostics service provider in Southeast Asia.



– The End –


About Quadria Capital


Quadria Capital is an independent healthcare focused private equity firm with assets under management exceeding US$ 1.5 billion and investments in 16companies across the Asia-Pacific region.


We focus on partnering with promising regional healthcare companies and, with our active investment strategy, help them grow into regional leaders, while creating and delivering outstanding returns to our investors.


We complement our investment objective with a progressive investment philosophy of creating positive impact on environment, society and governance. Our aim is to improve lives by bringing better healthcare for all. This comes from our belief that positive investment returns and constructive social and financial impact must go hand-in-hand.


The Fund is sponsored by Abrar Mir and Dr. Amit Varma and has operations based out of Singapore and New Delhi.


For more information, visit Quadria’s website at www.quadriacapital.com.